1. Hybridoma technology: comprehensive, customized hybridoma campaigns for therapeutic antibody discovery.
2. Naïve phage antibody libraries: LakePharma has licensed multiple naïve Fab libraries (XOMA, Moradec, etc.) and yeast display libraries, and employs them for unparalleled de novo antibody discovery.
3. Clonal B cells: B cell clones or single cells can be used as the starting point for molecular cloning.
Please contact LakePharma at email@example.com for custom quotes and details.